Search Results - "Sengelov, Henrik"

Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study by Granfeldt Østgård, Lene Sofie, Medeiros, Bruno C, Sengeløv, Henrik, Nørgaard, Mette, Andersen, Mette Klarskov, Dufva, Inge Høgh, Friis, Lone Smidstrup, Kjeldsen, Eigil, Marcher, Claus Werenberg, Preiss, Birgitte, Severinsen, Marianne, Nørgaard, Jan Maxwell

“…Secondary and therapy-related acute myeloid leukemia (sAML and tAML, respectively) remain therapeutic challenges. Still, it is unclear whether their inferior…”
Get full text

Detection of the novel HLA allele, HLA‐DRB108:112, identified in a Danish family by Plesner, Annette, Hald, Jacob, Sengeløv, Henrik, Bruunsgaard, Helle

“…HLA‐DRB1*08:112 differs from HLA‐DRB1*08:01 in exon 2 at amino acid 62; asparagine to lysine substitution…”
Get full text

Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation by Sengeløv, Henrik, Petersen, Peter M., Fog, Lotte, Schmidt, Mette, Specht, Lena

Get full text

Cytokine autoantibodies are stable throughout the haematopoietic stem cell transplantation course and are associated with distinct biomarker and blood cell profiles by von Stemann, Jakob Hjorth, Gjærde, Lars Klingen, Haastrup, Eva Kannik, Minculescu, Lia, Brooks, Patrick Terrence, Sengeløv, Henrik, Hansen, Morten Bagge, Ostrowski, Sisse Rye

“…Cytokine-specific autoantibodies (c-aAbs) represent an emerging field in endogenous immunodeficiencies, and the immunomodulatory potential of c-aAbs is now…”
Get full text

Ocular graft-versus-host disease and dry eye disease after paediatric haematopoietic stem cell transplantation - incidence and risk factors by Jeppesen, Helene, Kielsen, Katrine, Siersma, Volkert, Lindegaard, Jens, Julian, Hanne Olsen, Heegaard, Steffen, Sengeløv, Henrik, Müller, Klaus

“…Ocular graft-versus-host disease (oGVHD) contributes substantially to morbidity after allogeneic haematopoietic stem cell transplantation (HSCT) but is…”
Get full text

Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark – factors associated with risks and rates in adults according to conditioning regimen by Jeppesen, Helene, Sengeløv, Henrik, Eriksson, Frank, Kiilgaard, Jens Folke, Andersen, Susanne Tvede, Lindegaard, Jens, Julian, Hanne Olsen, Heegaard, Steffen

“…We investigated risks and hazard rates of developing chronic ocular graft-versus-host disease (oGVHD) in a large nationwide, single centre study by using the…”
Get full text

Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation by Ebbesen, Maria, Enevold, Christian, Juul, Anders, Heilmann, Carsten, Sengeløv, Henrik, Müller, Klaus

“…Allogeneic hematopoietic stem cell transplantation (HSCT) is challenged by significant toxicities that are propagated by systemic inflammation caused by…”
Get full text

Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients by Jørgensen, Mette, Nørgaard, Jens C., Ilett, Emma E., Marandi, Ramtin Z., Noguera-Julian, Marc, Paredes, Roger, Murray, Daniel D., Lundgren, Jens, MacPherson, Cameron Ross, Sengeløv, Henrik

“…Allogeneic hematopoietic stem cell transplantation (aHSCT) is a putative curative treatment for malignant hematologic disorders. During transplantation, the…”
Get full text

Identification of the novel HLA allele, HLA‐DPA101:46, identified in a man of Serbian origin by Mora‐Jensen, Helena Isabel, Hald, Jacob, Hauge, Anne Werner, Sengeløv, Henrik, Bruunsgaard, Helle

“…HLA‐DPA1*01:46 differs from HLA‐DPA1*01:03 in exon 2 at amino acid 85; Aspartate to Asparagine substitution…”
Get full text

Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease by Gjærde, Lars K., Schmidt, Mette, Sengeløv, Henrik

Get full text

Impact of Antibiotic Treatment on the Gut Microbiome and its Resistome in Hematopoietic Stem Cell Transplant Recipients by Nørgaard, Jens Christian, Jørgensen, Mette, Moestrup, Kasper Sommerlund, Ilett, Emma Elizabeth, Zucco, Adrian Gabriel, Marandi, Ramtin Z, Julian, Marc Noguera, Paredes, Roger, Lundgren, Jens D, Sengeløv, Henrik, MacPherson, Cameron

“…Abstract Antibiotic-resistant bacterial infections are increasingly an issue in allogenic hematopoietic stem cell transplant patients. How antibiotic treatment…”
Get full text

Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival by Nygaard, Marietta, Andersen, Niels Smedegaard, Moser, Claus Ernst, Olesen, Gitte, Schjødt, Ida Marie, Heilmann, Carsten, Sengeløv, Henrik

“…Several immunosuppressive drugs have been proposed for second-line treatment of steroid-refractory acute graft versus host disease (aGvHD) after allogeneic…”
Get full text

Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation by Gjærde, Lars K., Andersen, Niels S., Friis, Lone S., Kornblit, Brian, Petersen, Søren L., Schjødt, Ida, Ostrowski, Sisse R., Sengeløv, Henrik

Get full text

Epidemiology of bloodstream infections after myeloablative and non‐myeloablative allogeneic hematopoietic stem cell transplantation: A single‐center cohort study by Gjærde, Lars I., Moser, Claus, Sengeløv, Henrik

“…Background Patients who undergo allogeneic hematopoietic stem cell transplantation (allo‐HSCT) often develop bloodstream infections (BSI). We aimed to describe…”
Get full text

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia by Craddock, Charles, Labopin, Myriam, Robin, Marie, Finke, Juergen, Chevallier, Patrice, Yakoub-Agha, Ibrahim, Bourhis, Jean Henri, Sengelov, Henrik, Blaise, Didier, Luft, Thomas, Hallek, Michael, Kröger, Nicolaus, Nagler, Arnon, Mohty, Mohamad

“…Disease relapse is the most common cause of treatment failure after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic…”
Get full text

Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen—A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation by NAGLER, Arnon, ROCHA, Vanderson, SOCIE, Gerard, SENGELOV, Henrik, MICHALLET, Mauricette, PASSWEG, Jakob, VEELKEN, Hendrik, YAKOUB-AGHA, Ibrahim, SHIMONI, Avichai, MOHTY, Mohamad, LABOPIN, Myriam, UNAL, Ali, OTHMAN, Tarek Ben, CAMPOS, Antonio, VOLIN, Liisa, POIRE, Xavier, ALJURF, Mahmoud, MASSZI, Tamás

“…Cyclophosphamide (Cy) combined with total-body irradiation (TBI) or with busulfan (Bu) are currently the most common myeloablative regimens used in allogeneic…”
Get full text

Associations Between Mental Disorders in Donors and Matched Recipients of Hematopoietic Stem Cell Transplants: A Population-Based Cohort Study by Rømer, Troels Boldt, Sengeløv, Henrik, Christensen, Rune Haubo Bojesen, Benros, Michael Eriksen

“…Immunological mechanisms have been implicated in the development of mental disorders, and interestingly, case reports have suggested that hematopoietic stem…”
Get full text

Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition by Kverneland, Anders H., Borch, Troels Holz, Granhøj, Joachim, Sengeløv, Henrik, Donia, Marco, Svane, Inge Marie

“…Lymphodepletion with non-myeloablative (NMA) chemotherapy is currently a prerequisite for adoptive cell therapy (ACT). ACT based on tumor-infiltrating…”
Get full text

Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation by Minculescu, Lia, Marquart, Hanne Vibeke, Ryder, Lars Peter, Andersen, Niels Smedegaard, Schjoedt, Ida, Friis, Lone Smidstrup, Kornblit, Brian Thomas, Petersen, Søren Lykke, Haastrup, Eva, Fischer-Nielsen, Anne, Reekie, Joanne, Sengelov, Henrik

“…T-cell receptor (TCR) γδ cells are perceived as innate-like effector cells with the possibility of mediating graft-vs. -tumor (GVT) without causing…”
Get full text

The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party by Gjærde, Lars Klingen, Ruutu, Tapani, Peczynski, Christophe, Boreland, William, Kröger, Nicolaus, Blaise, Didier, Schroeder, Thomas, Peffault de Latour, Régis, Gedde-Dahl, Tobias, Kulagin, Aleksandr, Sengeløv, Henrik, Yakoub-Agha, Ibrahim, Finke, Jürgen, Eder, Matthias, Basak, Grzegorz, Moiseev, Ivan, Schoemans, Hélène, Koenecke, Christian, Penack, Olaf, Perić, Zinaida

“…Obesity and diabetes can modulate immune responses, which may impact allogeneic HCT outcomes and GvHD. From the EBMT registry, we included 36,539 adult…”
Get full text